Company / SG&A per Share
AMICUS THERAPEUTICS, INC. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.28
FY2025
5-year range
$0.74 / $1.28
FY2021-FY2025
Trend
+16.4%
vs FY2024
Sector context
#104 of 210
Health Care
What the data says
At $1.28, AMICUS THERAPEUTICS, INC.'s sg&a per share ranks #107 of 210 in the Health Care sector. SG&A per Share has increased for 5 consecutive years, from $0.60 in FY2020 to $1.28 in FY2025.
Based on SEC 10-K filings.
1.28 in FY2025 with a 5-year CAGR of +16.2%.
Increased from $0.98 to $1.28 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +18.9%
- 5-Year CAGR
- +16.2%
- 10-Year CAGR
- -
Sector benchmark
#107 of 210 in Health CareTop 50% of 210This company $1.28 Sector average $40.75
▼
-96.9% below sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s sg&a per share has grown for 5 consecutive years.
- In FY2025, sg&a per share increased 16.4% year-over-year.
- Ranks #104 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.28 | +16.4% |
| FY2024 | $1.10 | +12.5% |
| FY2023 | $0.98 | +28.2% |
| FY2022 | $0.76 | +3.9% |
| FY2021 | $0.74 | +21.7% |
| FY2020 | $0.60 | -14.5% |
| FY2019 | $0.71 | +3.2% |
| FY2018 | $0.68 | +10.2% |
| FY2017 | $0.62 | +9.2% |
| FY2016 | $0.57 | +15.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026